“…Overall, 88 studies with 33,098 cases and 37,831 controls were included in this meta-analysis. Of the 88 studies, 24 studies focused on breast cancer [ 9 – 11 , 16 , 38 , 60 , 61 , 68 , 69 , 71 , 72 , 77 , 88 , 93 , 96 , 97 , 100 , 105 , 109 , 114 , 119 , 122 , 127 ]; 17 on prostate cancer [ 37 , 66 , 74 , 79 , 82 , 85 , 86 , 89 , 95 , 106 , 111 , 113 , 120 , 125 , 128 ]; six for each of the following cancer types, such as lung cancer [ 7 , 17 , 18 , 65 , 92 , 118 ], bladder cancer [ 8 , 15 , 67 , 75 , 112 , 117 ], and pancreatic cancer [ 64 , 91 , 102 , 107 , 108 , 121 ]; five on colorectal cancer [ 13 , 63 , 73 , 94 , 101 ]; three for each of the following cancer types, such as ovarian cancer [ 70 , 81 , 87 ], hepatocellular carcinoma [ 98 , 99 , ...…”